Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17180.18 158.33 NIFTY 5103.55 51.10
 

Nectar Lifesciences Nine Months, Nectar Lifesciences Financial Statement & Accounts

Nectar Lifesciences

BSE: 532649  |  NSE: NECLIFE  |  ISIN: INE023H01027  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Nine Months of Nectar Lifesciences

------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
Sales Turnover 159.70 210.83 293.12 526.60 557.84
Other Income 4.61 10.91 14.57 11.20 2.01
Total Income 164.31 221.74 307.69 537.80 559.85
Total Expenses 145.43 190.54 249.18 439.69 446.22
Operating Profit 14.27 20.29 43.94 86.91 111.62
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- -- --
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 18.88 31.20 58.51 98.11 113.63
Interest 5.26 6.99 13.92 26.29 33.52
PBDT 13.61 24.20 44.59 71.81 80.12
Depreciation 4.36 4.71 6.24 11.08 23.04
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 9.25 19.49 38.35 60.73 57.08
Tax 1.97 3.11 4.84 1.46 0.12
Net Profit 7.28 16.38 33.51 59.27 56.96
Prior Years Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share 6.61 11.01 22.51 39.82 37.41
Book Value -- -- -- -- --
Equity 11.02 14.89 14.89 14.89 15.23
Reserves 48.52 157.98 191.85 252.76 --
Face Value 10.00 10.00 10.00 10.00 10.00
Source : Religare Technova
Explore Nectar Life connections